XML 50 R34.htm IDEA: XBRL DOCUMENT v3.6.0.2
ACQUISITIONS (Tables)
12 Months Ended
Dec. 31, 2016
Merck Serono  
Business Acquisition [Line Items]  
Summary of Estimated Fair Values of Assets Acquired and Liabilities Assumed

The following table presents the final allocation of the purchase consideration for the Merck PKU Business acquisition, including the contingent acquisition consideration payable based on the acquisition date fair value. The allocation of the purchase price below reflects an inventory adjustment in the second quarter of 2016.

 

Cash payments

 

$

374,545

 

Estimated fair value of contingent acquisition consideration payable

 

 

138,974

 

Total consideration

 

$

513,519

 

 

Kuvan intangible assets

 

$

172,961

 

Pegvaliase IPR&D

 

 

326,359

 

Inventory

 

 

14,199

 

Total identifiable assets acquired

 

$

513,519

 

 

Summary of Pro Forma Financial Information

The following unaudited pro forma financial information presents the combined results of operations of the Company and the Merck PKU Business as if the acquisition occurred on January 1, 2015. This unaudited pro forma financial information is presented for informational purposes only and is not necessarily indicative of the results of future operations that would have been achieved had the acquisitions taken place at the beginning of 2015.

 

 

 

2015

 

Total revenues

 

$

962,853

 

Net loss

 

$

(143,506

)

Net loss per share, basic and dilutive

 

$

(0.90

)

Weighted average common shares outstanding, basic and diluted

 

 

160,025

 

 

Prosensa Holding N.V  
Business Acquisition [Line Items]  
Summary of Estimated Fair Values of Assets Acquired and Liabilities Assumed

The following table presents the allocation of the purchase consideration for the Prosensa acquisition based on fair value.

 

Cash and cash equivalents

 

$

141,669

 

Trade accounts receivable

 

 

3,086

 

Other current assets

 

 

1,537

 

Property, plant and equipment

 

 

2,683

 

Intangible assets

 

 

497

 

Other assets

 

 

104

 

Acquired IPR&D

 

 

772,808

 

Total identifiable assets acquired

 

 

922,384

 

Accounts payable and accrued expenses

 

 

(68,799

)

Debt assumed

 

 

(57,053

)

Deferred tax liability

 

 

(193,202

)

Total liabilities assumed

 

 

(319,054

)

Net identifiable assets acquired

 

 

603,330

 

Goodwill

 

 

148,134

 

Net assets acquired

 

$

751,464